Literature DB >> 27767380

Landscape of warfarin and clopidogrel pharmacogenetic variants in Qatari population from whole exome datasets.

Ambily Sivadas1,2, Parul Sharma3, Vinod Scaria1,2,3.   

Abstract

AIM: Pharmacogenetic landscapes of commonly used antiplatelet drugs, warfarin and clopidogrel have been studied in-depth in many countries. However, there is a paucity of data to understand their patterns in the Arab populations. MATERIALS &
METHODS: We analyzed the whole exome sequencing datasets of 100 Qatar individuals available in public domain with this perspective.
RESULTS: We characterized the allelic distribution of variants routinely tested for warfarin and clopidogrel. We additionally evaluated the population stratification and its effect on allele frequency distribution. Our analysis points to ethnic differences in the frequency distribution even for the small population studied.
CONCLUSION: This is one of the first and most comprehensive pharmacogenetic maps of variants associated with warfarin and clopidogrel for an Arab population, which can help tailor the drug dosage to the population.

Entities:  

Keywords:  Arab; Qatar; clopidogrel; pharmacogenetics; warfarin; whole exome

Year:  2016        PMID: 27767380     DOI: 10.2217/pgs-2016-0130

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  7 in total

1.  al mena: a comprehensive resource of human genetic variants integrating genomes and exomes from Arab, Middle Eastern and North African populations.

Authors:  Remya Koshy; Anop Ranawat; Vinod Scaria
Journal:  J Hum Genet       Date:  2017-06-22       Impact factor: 3.172

2.  Incidental and clinically actionable genetic variants in 1005 whole exomes and genomes from Qatar.

Authors:  Abhinav Jain; Shrey Gandhi; Remya Koshy; Vinod Scaria
Journal:  Mol Genet Genomics       Date:  2018-03-20       Impact factor: 3.291

3.  Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations.

Authors:  Haifa Jmel; Lilia Romdhane; Yosra Ben Halima; Meriem Hechmi; Chokri Naouali; Hamza Dallali; Yosr Hamdi; Jingxuan Shan; Abdelmajid Abid; Henda Jamoussi; Sameh Trabelsi; Lotfi Chouchane; Donata Luiselli; Sonia Abdelhak; Rym Kefi
Journal:  PLoS One       Date:  2018-04-13       Impact factor: 3.240

Review 4.  Genomics of rare genetic diseases-experiences from India.

Authors:  Sridhar Sivasubbu; Vinod Scaria
Journal:  Hum Genomics       Date:  2019-09-25       Impact factor: 4.639

5.  The Effect of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in the MENA Region: A Systematic Review.

Authors:  Zainab Ali; Hazem Elewa
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

6.  Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management.

Authors:  Islam Eljilany; Mohamed Elarref; Nabil Shallik; Abdel-Naser Elzouki; Loulia Bader; Ahmed El-Bardissy; Osama Abdelsamad; Daoud Al-Badriyeh; Larisa H Cavallari; Hazem Elewa
Journal:  Pharmgenomics Pers Med       Date:  2021-08-28

7.  Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait.

Authors:  Abdullah Albassam; Shahad Alshammari; Ghadeer Ouda; Samuel Koshy; Abdelmoneim Awad
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.